Ze Tian
Ze Tian
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,✉,
Chunhua Shi
Chunhua Shi
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,#,
Guojun Yang
Guojun Yang
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,#,
Jason K Allen
Jason K Allen
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,#,
Qing Shi
Qing Shi
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,#,
Amin AL-Shami
Amin AL-Shami
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Jill Wardell Olson
Jill Wardell Olson
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Melinda G Smith
Melinda G Smith
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Qing Chang
Qing Chang
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Jasbir Kaur
Jasbir Kaur
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Junping You
Junping You
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Timothy E Lofton
Timothy E Lofton
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Michelle A Gonzalez
Michelle A Gonzalez
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Qi Zhang
Qi Zhang
2Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX USA
2,
DongXing Zha
DongXing Zha
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,
Sarah K Tasian
Sarah K Tasian
3Division of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia; Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA USA
3,
Nitin Jain
Nitin Jain
2Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX USA
2,
Marina Y Konopleva
Marina Y Konopleva
2Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX USA
2,
Timothy Heffernan
Timothy Heffernan
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
4Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,4,✉,
Jeffrey J Molldrem
Jeffrey J Molldrem
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
5Department of Hematopoietic Biology & Malignancy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX USA
1,5,✉
1ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, TX USA
2Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX USA
3Division of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia; Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA USA
4Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX USA
5Department of Hematopoietic Biology & Malignancy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX USA
Subject terms: Cancer immunotherapy, Immunotherapy
© The Author(s) 2023
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
